Active Ingredient: DICLOFENAC SODIUM
Proprietary Name: SOLARAZE
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021005
Product Number: 001
Approval Date: Oct 16, 2000
Applicant Holder Full Name: FOUGERA PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information